DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Neuraltus P.
Neuraltus Pharmaceuticals reports clinical results from phase 1 NP001 study in the treatment of amyotrophic lateral sclerosis (ALS).
Available at:
http://www.neuraltus.com/pages/news_rel11_30_10.html . Accessed May 22, 2012
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.